Regeneron Announces Investor Conference Presentations

Rhea-AI Summary

Regeneron (NASDAQ: REGN) will webcast management presentations at two investor conferences in March 2026: TD Cowen 46th Annual Health Care Conference on March 4, 2026 at 9:10 a.m. ET and Leerink Partners 2026 Global Healthcare Conference on March 11, 2026 at 10:40 a.m. ET.

According to the company, sessions are accessible via its Investors & Media page, with replays and transcripts archived on the website for at least 30 days.

AI-generated analysis. Not financial advice.

News Market Reaction – REGN

+0.60%

1 alert

+0.60% News Effect

On the day this news was published, REGN gained 0.60%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TARRYTOWN, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

• TD Cowen 46th Annual Health Care Conference at 9:10 a.m. ET on Wednesday, 
  March 4, 2026
  
  
• Leerink Partners 2026 Global Healthcare Conference at 10:40 a.m. ET on Wednesday, 
  March 11, 2026
  
  

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company's website for at least 30 days.

About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. 

Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite^®, which produces optimized fully human antibodies and new classes of bispecific antibodies. We are shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center^® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.

Contact Information:
Investor Relations
Ryan Crowe
914.847.8790
ryan.crowe@regeneron.com

FAQ

When will Regeneron (REGN) present at the TD Cowen 46th Annual Health Care Conference?

Regeneron will present on March 4, 2026 at 9:10 a.m. ET. According to the company, the session will be webcast and available via the Investors & Media page, with replay and transcript archived for at least 30 days after the event.

How can investors watch Regeneron (REGN) at the Leerink Partners 2026 Global Healthcare Conference?

Investors can watch the Regeneron presentation live via webcast on the company’s Investors & Media page. According to the company, the Leerink session on March 11, 2026 at 10:40 a.m. ET will have replays and transcripts available for at least 30 days.

Will Regeneron (REGN) provide replays or transcripts of the March 2026 presentations?

Yes. According to the company, replays and transcripts of the webcasts will be archived on its website for at least 30 days. Investors can access archived materials from the Investors & Media page after each conference presentation for on-demand review.

Where is the Regeneron (REGN) webcast for the March 4 and March 11, 2026 events hosted?

The webcasts are hosted on Regeneron’s Investors & Media web page. According to the company, both the TD Cowen and Leerink conference sessions will be accessible there, with on-demand replay and transcript access for a minimum 30-day archival period.

Do the Regeneron (REGN) conference webcasts require registration to view live or on replay?

The company indicates webcasts are available via its Investors & Media page, generally accessible without special registration. According to the company, live viewing and archived replays and transcripts are posted on the site for at least 30 days.